SCHEMBL1445117

SCHEMBL1445117

c1ccc2c(-c3ccncn3)ccnc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFATC1 O95644 1/20 0.48
▸ DYRK1A Q13627 1/20 0.48
▸ TGFBR1 P36897 6/20 0.47
▸ MAPK14 Q16539 4/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ NCF1 P14598 1/20 0.44
▸ TGFBR2 P37173 1/20 0.43
▸ ABL2 P42684 1/20 0.43
▸ CSNK1A1 P48729 1/20 0.43
▸ CSNK1D P48730 1/20 0.43
▸ MAP3K20 Q9NYL2 1/20 0.43
▸ ESR1 P03372 1/20 0.43
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6627903 0.79 TGFBR1 (0.67) TGFBR1MAPK14CYP1A2NPC1RAB9A
SCHEMBL1227713 0.78 CYP1A2 (0.60) NFATC1DYRK1ATGFBR1MAPK14CYP1A2
SCHEMBL29699887 0.78 CYP1A2 (0.60) NFATC1DYRK1ATGFBR1MAPK14CYP1A2
SCHEMBL27917128 0.78 CYP1A2 (0.60) NFATC1DYRK1ATGFBR1MAPK14CYP1A2
SCHEMBL17689700 0.78 CYP11B1 (0.47) TGFBR1MAPK14NPC1RAB9AKDM4E
SCHEMBL24412111 0.77 CYP3A4 (0.39) NFATC1DYRK1ATGFBR1MAPK14NPC1
SCHEMBL10601314 0.76 MAPK9 (0.43) MAPK14CSNK1A1
SCHEMBL30487734 0.76 CYP1A2 (0.58) NFATC1DYRK1ATGFBR1MAPK14CYP1A2
SCHEMBL27898092 0.76 PIK3CA (0.65) NFATC1DYRK1ATGFBR1MAPK14CYP1A2
SCHEMBL14725237 0.76 MAPK9 (0.38) MAPK14CSNK1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480235-A2 NOVEL IODO PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-IMPLICATED DISEASES AND CONDITIONS University Of Louisville Research Foundation, Inc. (US) 2012-08-01 — — EP claimed
WO-2011038234-A2 NOVEL IODO PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-IMPLICATED DISEASES AND CONDITIONS UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2011-03-31 — — WO claimed
Send feedback